Stem Cell Authority Ltd. (SCAL)

Overview

Stem Cell Authority, Ltd. is a technology development company concentrated on the forefront of regenerative medicine. Its primary mission revolves around the collection and cryogenic preservation of stem cells, a cutting-edge approach aimed at harnessing the potential future benefits of these cells. The company stands out for its specialization in securing hematopoietic stem cells from umbilical cord blood and Miracle Mesenchymal stem cells found in the Wharton's jelly of the umbilical cord. Based in Fairlawn, Ohio, Stem Cell Authority, Ltd. provides pivotal technology and services that empower birthing professionals to offer comprehensive stem cell preservation programs to maternity patients across the United States.

Products and Services

• Collection and Cryogenic Preservation of Hematopoietic Stem Cells:

This service involves the safe and efficient extraction of hematopoietic stem cells from umbilical cord blood immediately after childbirth. These cells are known for their ability to transform into any type of blood cell and are instrumental in the treatment of a plethora of diseases, including various forms of cancer, blood disorders, and immune system conditions. Following collection, the cells undergo a cryogenic preservation process, ensuring their viability for future therapeutic applications.

• Miracle Mesenchymal Stem Cell Preservation:

Focusing on the Wharton's jelly within the umbilical cord, this service captures the Miracle Mesenchymal stem cells renowned for their regenerative properties. Unlike the hematopoietic stem cells, these are multipotent, capable of differentiating into a variety of cell types such as bone, cartilage, and muscle cells. The process mirrors that of the hematopoietic stem cell service, with the cells being cryogenically preserved post-collection for potential future medical interventions.

• Stem Cell Preservation Program Support for Birthing Professionals:

Stem Cell Authority, Ltd. extends its technological expertise to birthing professionals, equipping them with the necessary tools and protocols to integrate stem cell preservation services into their practice. This encompasses education on the importance and benefits of stem cell preservation, training on collection procedures, and support for storage logistics. By doing so, the company enhances the capacity of healthcare providers to offer this valuable service to maternity patients, contributing to the broader accessibility of stem cell therapies.